Evidence map›Paper›PMID 33806730›Full record

ReviewInternational journal of molecular sciences2021

Mitochondrial Transfer in Cancer: A Comprehensive Review.

Luca X Zampieri, Catarina Silva-Almeida, Justin D Rondeau, Pierre Sonveaux

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Mitochondrial transfer in the HSC-HCC-macrophage network shapes hepatocellular carcinoma progression.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Review
  14. Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luca X ZampieriPole of Pharmacology, Institut de Recherche Experimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Avenue Hippocrate 57 Box B1.57.04, 1200 Brussels, Belgium.ORCID 0000-0002-9286-7693
Catarina Silva-AlmeidaPole of Pharmacology, Institut de Recherche Experimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Avenue Hippocrate 57 Box B1.57.04, 1200 Brussels, Belgium.
Justin D RondeauPole of Pharmacology, Institut de Recherche Experimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Avenue Hippocrate 57 Box B1.57.04, 1200 Brussels, Belgium.
Pierre SonveauxPole of Pharmacology, Institut de Recherche Experimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Avenue Hippocrate 57 Box B1.57.04, 1200 Brussels, Belgium.ORCID 0000-0001-6484-8834
UCLouvain · BE

Funding

Belgian Télévie n/aFondation Belge contre le Cancer FAF-F/2018/1282Fondation Louvain n/aFonds De La Recherche Scientifique - FNRS n/aH2020 Marie Skłodowska-Curie Actions 722605 (TRANSMIT) and 860245 (THERADNET)
6 · The paper itself

Abstract

Depending on their tissue of origin, genetic and epigenetic marks and microenvironmental influences, cancer cells cover a broad range of metabolic activities that fluctuate over time and space. At the core of most metabolic pathways, mitochondria are essential organelles that participate in energy and biomass production, act as metabolic sensors, control cancer cell death, and initiate signaling pathways related to cancer cell migration, invasion, metastasis and resistance to treatments. While some mitochondrial modifications provide aggressive advantages to cancer cells, others are detrimental. This comprehensive review summarizes the current knowledge about mitochondrial transfers that can occur between cancer and nonmalignant cells. Among different mechanisms comprising gap junctions and cell-cell fusion, tunneling nanotubes are increasingly recognized as a main intercellular platform for unidirectional and bidirectional mitochondrial exchanges. Understanding their structure and functionality is an important task expected to generate new anticancer approaches aimed at interfering with gains of functions (e.g., cancer cell proliferation, migration, invasion, metastasis and chemoresistance) or damaged mitochondria elimination associated with mitochondrial transfer.

Indexed as

AnimalsBiological TransportCell ProliferationCell SurvivalCell Transformation, NeoplasticCitric Acid CycleDisease ProgressionDrug Resistance, NeoplasmEnergy MetabolismHumansMetabolic Networks and PathwaysMicrotubulesMitochondriaNeoplasmsOxidative PhosphorylationReactive Oxygen SpeciesReactive Oxygen Speciescancercancer metabolismchemoresistancemetastasismitochondriamitochondrial transferoxidative phosphorylation (OXPHOS)reactive oxygen species (ROS)tricarboxylic acid (TCA) cycletunneling nanotubes (TNT)

Identifiers

PMID33806730
PMCPMC8004668
OpenAlexW3136170423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.